Generic drugs are expected to enjoy a banner year in 2011, prompting some investment pros to reformulate their portfolios to get a jump on the transition. For Goldman Sachs, that means betting on several wholesale distributors and retail drugstores that stand to benefit.
Continue reading Inside Wall Street: How Goldman Is Playing the Coming Tide of Generic Drugs
Inside Wall Street: How Goldman Is Playing the Coming Tide of Generic Drugs originally appeared on DailyFinance on Wed, 02 Mar 2011 07:30:00.
Filed Under: Company News, Columns, Investing, Health Care, Goldman Sachs , Stock Picks